|  |  |  |  |  |
| Company | IBL-America | IBL-America | IBL-America | IBL-America | IBL-America |
| Item | Coxiella burnetii (Q-Fever) Phase 1 IgG ELISA Assay | Bevacizumab (Avastin®) ELISA | Endothelial Lipase (EL) C-Terminal ELISA | Prolactin IRMA Assay | sAPP Beta-w (Highly Sensitive) ELISA Assay |
| Citations | | | | | |
| Catalog Number | IB79833 | TM09010 | 27263 | KIP1441 | 27732 |
| Price | Supplier Page | Supplier Page | Supplier Page | Supplier Page | Supplier Page |
| Description | Enzyme immunoassay (ELISA) for the determination of IgG class antibodies against Coxiella burnetii phase 1 in the early stages of infection in human serum. For research use only, not for use in diagnostic procedures. | Enzyme immunoassay (ELISA) test kit for the determination of free antibodies directed against the drug Bevacizumab (Avastin®) in serum and plasma. For research use only, not for use in diagnostic procedures. | Solid phase sandwich enzyme-linked immunosorbent assay (ELISA) for the determination of Endothelial Lipase (EL) C-Terminal in human serum and EDTA-plasma. For research use only, not for use in diagnostic procedures. | Immunoradiometric assay (RIA) for the determination of human prolactin (PRL) in serum and plasma. FDA exempt, can be used for in-vitro diagnostics. | Solid phase sandwich ELISA for the determination human sAPPß-w in EDTA plasma, cerebrospinal fluids and cell culture supernatant. For research use only, not for use in diagnostic procedures. |
| Detection Target | Coxiella burnetii (Q-Fever) Phase 1 IgG | Bevacizumab (Avastin®) | Noradrenaline | Insulin | Bordetella pertussis IgM |
| Sample Type | Serum | Serum and plasma. | Multiple | Serum, Blood Plasma | Serum, Blood Plasma |
| Method | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Radio Immuno Assay (RIA) | Enzyme-Linked Immunosorbent Assay (ELISA) |
| Detection Range | Inquire | 0 / 6 to 200 ng/mL | 0 / 0.13 to 8 ng/mL | 2.8 to 133 ng/mL | 0.78 to 50 ng/mL |
| Sensitivity | 88% | 2 ng/mL | 0.1 ng/mL x Correction Factor (please see protocol) | 1.76 µIU/mL | 89.19 % (95% confidence interval: 74.58% - 96.97%) |
| Assay Time | 1 hr 45 mins (incubation) | 1 hour, 45 min. total incubation time. | Overnight + 30 min. (incubation) | 2 hrs (incubation) | Overnight + 1 hr (incubation) |
| Get Quote | Supplier Page | Supplier Page | Supplier Page | Supplier Page | Supplier Page |